Deep learning characterization of brain tumours with diffusion weighted imaging.
Applied mathematics
Cancer
Deep learning
Machine learning
Mathematical medicine
Mathematical oncology
Medical imaging
Neural networks
PDEs
Journal
Journal of theoretical biology
ISSN: 1095-8541
Titre abrégé: J Theor Biol
Pays: England
ID NLM: 0376342
Informations de publication
Date de publication:
21 01 2023
21 01 2023
Historique:
received:
28
04
2022
revised:
19
10
2022
accepted:
30
10
2022
pubmed:
12
11
2022
medline:
23
11
2022
entrez:
11
11
2022
Statut:
ppublish
Résumé
Glioblastoma multiforme (GBM) is one of the most deadly forms of cancer. Methods of characterizing these tumours are valuable for improving predictions of their progression and response to treatment. A mathematical model called the proliferation-invasion (PI) model has been used extensively in the literature to model the growth of these tumours, though it relies on known values of two key parameters: the tumour cell diffusivity and proliferation rate. Unfortunately, these parameters are difficult to estimate in a patient-specific manner, making personalized tumour forecasting challenging. In this paper, we develop and apply a deep learning model capable of making accurate estimates of these key GBM-characterizing parameters while simultaneously producing a full prediction of the tumour progression curve. Our method uses two sets of multi sequence MRI in order to produce estimations and relies on a preprocessing pipeline which includes brain tumour segmentation and conversion to tumour cellularity. We first apply our deep learning model to synthetic tumours to showcase the model's capabilities and identify situations where prediction errors are likely to occur. We then apply our model to a clinical dataset consisting of five patients diagnosed with GBM. For all patients, we derive evidence-based estimates for each of the PI model parameters and predictions for the future progression of the tumour, along with estimates of the parameter uncertainties. Our work provides a new, easily generalizable method for the estimation of patient-specific tumour parameters, which can be built upon to aid physicians in designing personalized treatments.
Identifiants
pubmed: 36368560
pii: S0022-5193(22)00333-2
doi: 10.1016/j.jtbi.2022.111342
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
111342Informations de copyright
Copyright © 2022 Elsevier Ltd. All rights reserved.